This trial, conducted in 2016 with a 104-week follow-up, occurred prior to widespread real-world use of this medication group and examined cardiovascular rather than ocular outcomes
Factors that can trigger or worsen melasma include: Adopting a melasma-friendly lifestyle, including sun avoidance, stress management, anti-inflammatory nutrition, and hormone balance, can significantly support treatment success
Oral GLP-1s will need to be taken at least once daily compared to the once-weekly treatment schedules of Lillys Zepbound and Novos Wegovy, meaning many more doses will need to be created
Once reconstituted in bacteriostatic water or sterile saline, most peptides remain stable for 2 to 6 weeks when refrigerated at 28 C
For more than three years, injectable medications such as Wegovy and Zepbound have helped medical weight loss patients at New Jersey Bariatric Center lose on average 15-20% of their excess body weight